The continuing challenges facing gene-targeted therapies
- PMID: 37104715
- DOI: 10.1111/dmcn.15584
The continuing challenges facing gene-targeted therapies
References
REFERENCES
-
- Morris JA, Boshoff CH, Schor NF, et al. Next-generation strategies for gene-targeted therapies of central nervous system disorders: A workshop summary. Mol Ther 2021; 29: 3332-44.
-
- Kim U, Lee DS. Epigenetic regulations in mammalian cells: Roles and profiling techniques. Mol Cells 2023; 46: 86-98.
-
- Jiang S, Huang Z, Li Y, et al. Single-cell chromatin accessibility and transcriptome atlas of mouse embryos. Cell Rep 2023; 42: 112210.
-
- Amanat M, Nemeth CL, Fine AS, Leung DG, Fatemi A. Antisense oligonucleotide therapy for the nervous system: From bench to bedside with emphasis on pediatric neurology. Pharmaceutics 2022; 14: 2389.
-
- Lekstrom-Himes J, Brooks PJ, Koeberl DD, et al. Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies. Am J Med Genet C Semin Med Genet 2023; 193: 30-43.
Publication types
LinkOut - more resources
Full Text Sources
